5-alpha Reductase Inhibitors

DBCAT001276Therapeutic categoryG04CB

Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE. A DrugBank category of 7 drugs. 4 of them are approved.

ATC classification: G — GENITO URINARY SYSTEM AND SEX HORMONES
G04 — UROLOGICALS
G04C — DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
G04CB — Testosterone-5-alpha reductase inhibitors
Also known as: 3 Oxo 5 alpha Steroid 4 Dehydrogenase Inhibitors · 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Inhibitors · 4-Dehydrogenase Inhibitors, 3-Oxo-5-alpha-Steroid · 5 Alfa Reductase Inhibitors · 5 alpha Reductase Inhibitors
Drugs: Bexlosteride
Dutasteride
Epristeride
Finasteride
Methylhexaneamine
Tadalafil
Turosteride

What you can answer from here — as of May 27, 2018

7DrugsEach linked to its full drug card

Listed above

9Drug targetsEvery drug–target pair in the class, with bond type

2,769Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do 5-alpha Reductase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account